Pituitary carcinomas: Rare and challenging.

Area of Science:

• Endocrinology
• Neuro-oncology
• Oncopathology

Background:

• Pituitary carcinomas (PCs) are rare adenohypophyseal tumors with metastatic potential within and beyond the central nervous system (CNS).
• PCs are often hormone-producing and exhibit complex clinical evolution, posing management challenges.
• Limited case reports highlight the rarity and diagnostic difficulties associated with pituitary carcinomas.

Observation:

• A 58-year-old patient with a history of prolactinoma since 2005 experienced persistent local tumor growth despite multimodal therapy.
• The patient developed central nervous system (CNS) metastases in 2017, necessitating aggressive treatment including surgery, radiotherapy, and systemic therapy.
• The case illustrates the challenging and often protracted course of pituitary carcinomas.

Findings:

• Pituitary carcinomas necessitate individualized, multimodal treatment strategies based on tumor infiltration, invasion patterns, and hormonal activity.
• The presented case underscores the difficulties in achieving local tumor control and managing metastatic spread in pituitary carcinomas.
• Effective management requires a comprehensive approach tailored to the specific characteristics of the pituitary carcinoma.

Implications:

• Further research is needed to elucidate the mechanisms driving the extra-sellar and distant metastatic activity of pituitary carcinomas.
• Identifying reliable biomarkers for pituitary carcinoma risk is crucial for early diagnosis, prevention, and personalized treatment strategies.
• Understanding PC biology is essential for developing novel therapeutic interventions and improving patient outcomes.